Market Advisor's
Top Ten Stocks
for 2010

Stock #1 -- This market leader gained more than +150% last year and is poised to crush the S&P yet again in 2010.

Stock #2
-- The combination of increasing silver production and rising silver prices point to a second consecutive year of +100%-plus gains for this "silver streamer."

Stock #3 -- The agriculture business is booming -- the sector has returned +27% a year for the last five years with no slow-down in sight. As demand for food, fuel, and feed continues to soar, cash should continue to flow into the pockets of this firm and its happy shareholders.

Scroll down to learn more about all ten of our top investing ideas for the
coming year!

In this special 25-page report, Paul Tracy and Nathan Slaughter bring you an in-depth look at their favorite investing ideas for the upcoming year.

And if history is any guide...

...then we're 100% confident that you'll benefit from their ten BRAND NEW investing ideas for the 2010 calendar year.

Dear Investor,

After hundreds of hours of research, due diligence and healthy intra-company debate, Paul Tracy, Nathan Slaughter, and the StreetAuthority Market Advisor investment research team have narrowed the vast investing universe down to just 10 stocks poised to deliver above-average returns not only throughout the 2010 calendar year, but also in the years that follow.

Mr. Tracy and Mr. Slaughter hand-picked all 10 of these stocks using the same principles that helped them trounce the market for the past seven years.

In fact, they have more than DOUBLED the return of the S&P 500 since they began publishing this report back in 2003 -- posting +96.6% compounded returns!

Just look at some of the winning individual stocks they've identified in this very same report over the past seven years...

Symbol

Return

CPG +72.7%
GS +46.3%
CARS +43.2%
IYR +37.0%
CPL +72.1%
PNRA +45.8%
DIG +20.5%
Symbol

Return

MLS +50.3%
EV +43.8%
TTWO +20.7%
GILD +20.1%
NAI +61.8%
HGI +50.0%
EDD +42.0%
Symbol

Return

WFMI +63.3%
TEVA +47.7%
CEDC +42.8%
FAF +38.9%
DEM +58.1%
GDX +36.7%
SEA +27.5%
Symbol

Return

KMX +77.9%
FXI +62.2%
IGT +50.3%
DEO +38.0%
IGT +49.9%
XOP +40.1%
PAC +45.8%

Although past performance is no guarantee of future results, we're encouraged by their history of success and we're confident that you'll benefit from their newest in-depth report -- Market Advisor's Top Ten Stocks for 2010.

If you value consistency, this is one report you should get your hands on.

Thanks to your status as a loyal reader, we've reserved a special copy of this report for you. Please click below to claim your copy today...

Important: You can only receive this research report -- Market Advisor's Top Ten Stocks for 2010 -- through today's special offer. Act now and you'll also receive three months of our premium Market Advisor newsletter for only $39.50.

Best of all, this subscription comes with absolutely zero risk. You can cancel any time by clicking on the easy unsubscribe link we provide at the bottom of every single issue we'll send you. Take 90 days to test the newsletter out. If you decide to cancel any time within those first 90 days, then we'll return your entire subscription fee -- every single cent. You'll also get to keep our in-depth research report -- Market Advisor's Top Ten Stocks for 2010 -- as a special thank-you gift just for giving us a try. You truly have nothing to lose.

Lock in this special discount and get your copy of our newest report -- Market Advisor's Top Ten Stocks for 2010 -- before time runs out! This offer expires soon.

Keep reading for a sneak preview of all 10 of our top investment ideas for the coming year...

1. Stock #1 - "There's Good Money in Drugs"

.

StreetAuthority Catalyst Rating:
Business: Drug Delivery
Enterprise Value:$8.8B
Operating Margin:16%
Proj. EPS Growth: +15.6%
Recent Price: $47.05
Buy Under: $55
Catalysts:

Stock #1 is already profiting from biogeneric drugs in Europe and will be the prime beneficiary of a breakthrough in the U.S.

The acquisition of an Australian-based specialist in cancer injectables has paved the way for meaningful expansion in foreign markets.


In November's issue of Market Advisor, we made the case that a growing chorus of congressional voices will soon bring down the barrier that has long protected biotech drug companies from the threat of generic competitors. Formal approval by the U.S. Food and Drug Administration of biogenerics is in the works -- and a changing regulatory climate could give birth to a whole new industry.

Stock #1 will undoubtedly be at the forefront. The company already knows a thing or two about generic drugs. It's the world's leading supplier of generic injectable drugs -- which are far more complex than pills, and carry stronger margins. The company also has a dominant share of IVs and other medical infusion delivery systems found in hospitals, with an installed base 400,000 strong.

Last year, the firm became the first U.S. company to crack into the biogenerics field by unveiling a drug used to treat anemia in several European markets. This is just one of more than a dozen new biogeneric drugs in the development pipeline, to say nothing of generic injectables for traditional drugs that are coming off patent protection.

The company broke the $1 billion quarterly sales threshold for the first time in the third quarter of 2009 and management has boldly lifted its earnings outlook twice recently -- with the latest forecast calling for a profit of $2.90 a share this year.

Even without the massive dose of adrenaline the shares would receive from biogeneric approval in the United States, Stock #1 is clearly headed in the right direction.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


2. Stock #2 - "Trillions of Dollars are at Stake"

.

StreetAuthority Catalyst Rating:
Category: Financial Sector
Assets:$105M
Expense Ratio:0.35%
# of Holdings: 25
Recent Price: $35.55
Buy Under: $45
Catalysts:

More than $55 billion has come off the sidelines and into the market in recent months, but roughly $2 trillion still remains -- and a rising tide will lift all boats.

The world's financial markets revolve around the companies in this portfolio. Current valuations don't reflect their powerful competitive advantages and robust cash flow potential.

Top Five Holdings: Goldman Sachs (9.9%), Morgan Stanley (8.4%), State Street (8.0%), CME Group (6.2%), Charles Schwab (6.0%)


Keeping the world's capital markets well-oiled and running smoothly isn't an easy job, but it's definitely one that pays well. Under normal circumstances, Wall Street icons like Morgan Stanley seem to print their own money. Thanks to Stock #2, retail investors can sit on the same side of the table as the big boys.

As we all know, the financial sector was at the heart of 2008's meltdown. But the market rebounded sharply in 2009 -- and the data point resoundingly in favor of a sunnier economic climate in 2010. As if to reaffirm that outlook, barely a day goes by when a company doesn't hike its earnings guidance for the new year.

This backdrop should provide more fuel for the rally, and rising equity prices are the straw that stirs this powerful cocktail. When stocks are up, investors place more trades with their brokers and funnel more cash into their 401ks. When optimism is high, merger and acquisition activity heats up and IPOs come in bunches.

Stock #2 will ride at the crest of this wave. Its well-rounded portfolio offers investors a stake in two dozen of the world's premier investment banks, exchanges, broker/dealers and mutual fund managers.

You'll get a piece of dominant firms like NYSE Euronext, which is home to $30 trillion in market capitalization and collects bountiful fees for every stock listed and traded on its exchanges. The list also includes State Street, the nation's number one mutual fund custodian and pension plan servicer.

Then there's TD Ameritrade, which handled 431,000 trades a day in August (a sharp +71% increase from the previous year), and Eaton Vance, whose assets under management have swelled to $157 billion from $144 billion during the past couple months.

A buoyant market will only encourage heavier trading volume and mutual fund inflows in the months ahead. Meanwhile, a seismic shakeup in the investment banking business could also play a positive role, as the abrupt disappearance of venerable companies like Lehman Brothers has concentrated market share in the hands of the survivors.

Goldman Sachs -- Stock #2's top holding -- is raking in revenue by the bucketful -- $130 million a day last quarter. Profits more than tripled to reach $3.2 billion, or $5.25 per share. This was no fluke: Earnings from the prior quarter came in at $3.4 billion -- the most ever in the firm's storied 140-year history.

Goldman, Morgan Stanley and others are back to their winning ways. They have confounded the skeptics by churning out mountains of cash even after deleveraging their balance sheets and dialing down risk -- not to mention repaying huge chunks of borrowed TARP money.

Wall Street has cheered the dramatic reversal in the financial sector, but valuations are highly compelling. In fact, most of the fund's key holdings trade at cheap single-digit forward earnings multiples. We think those earnings targets are on the conservative side -- many firms have pared expenses to the bone, so any future revenue growth should fall straight to the bottom line.

Stock #2 already rebounded +100% in 2009, doubling the S&P and outrunning 92% of its category rivals. But there is still quite a bit of ground to make up, and the shares will need to double again from here to retake levels in the lower $70s, where they traded before the bottom fell out. And we think they are ticketed for a return trip in 2010.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


3. Stock #3 - "Consistency Counts"

.

StreetAuthority Catalyst Rating:
Category: Natural Resources
Assets:$94M
Expense Ratio:0.75%
# of Holdings: 286
Recent Price: $33.07
Buy Under: $42
Catalysts:

Whenever inflation heats up, there's no better place to park your cash than in tangible commodities -- these stocks posted gains of +400%-plus during the last serious bout.

A crumbling dollar and renewed demand from emerging markets like China only strengthen the arguments for commodities producers.

Top Five Holdings: Monsanto (5.5%), Exxon Mobil (5.0%), Potash (4.2%), Syngenta (3.4%), Archer Daniels Midland (2.8%)


In November's issue of Market Advisor, we spelled out a number of iron-clad reasons inflation is likely headed higher and the dollar is destined to move lower. These separate but related macroeconomic tidal forces can exert tremendous pull on the market -- and they are both tugging in the same direction.

The environment is starting to look conducive for Treasury Inflation-Protected Securities (TIPS), but history has shown conclusively that there is one asset class that thrives even more under these hostile conditions: commodities.

There are several reasons a depreciating dollar is a sure-fire recipe for rising commodity prices. The simplest is that goods denominated in dollars, like commodities, suddenly become cheaper for foreign buyers. And when inflation is on the rampage, investors like the reassurance of owning hard assets. Instead of watching prices for things like steel and gasoline rise all around you, why not convert your dollars into these commodities directly and enjoy the ride?

StreetAuthority's Tom Hutchison has dug up some illuminating stats on this. When the Consumer Price Index shot through the roof between May 1972 and December 1974, the S&P Commodities Index more than tripled. During the next decade, as stagflation made life miserable for equity and fixed income investors, commodities posted a whopping cumulative return of +479%.

Even if the Fed does manage to keep inflation in check, we believe that good old supply-and-demand fundamentals favor rising prices anyway. With the global economy getting back on track and emerging powers like China swallowing mountains of raw materials, the short-circuited commodities rally will have juice once again.

We're already seeing a taste of that. Oil is back near $80 per barrel, gold has pierced $1,100 an ounce and copper has surged more than +100% to touch a new 13-month peak of $3 a pound. Prices for staples like coal, natural gas, wheat and others could be headed skyward as well.

Investors have a dizzying array of options here, but our odds-on favorite is Stock #3 -- an ETF whose 300-stock portfolio provides one-stop shopping for six distinct commodity sub-sectors.

Top billing goes to the energy sector, where integrated oil & gas giants, offshore drillers and equipment/service providers soak up about 40% of the fund's assets. Elsewhere, shareholders will have a large stake in agricultural firms like Monsanto that supply bio-engineered seeds, fertilizer, irrigation equipment and everything else needed to maximize the yield of farmland.

The portfolio also provides ample exposure to gold and silver producers, along with well-positioned companies like Southern Copper that bring us aluminum, nickel, iron ore and other critical industrial metals. Rounding out the portfolio are holdings linked to coal, steel, uranium and even forest products.

Whether it's to protect purchasing power against the ominous threat of currency debasement or a simple bet on stronger economic expansion, both point to a continued run-up in commodity prices. And as we've said before, the companies that bring us these goods can deliver much "more reliable" gains than the futures pits.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .



4. Stock #4 - "This Silver Stock is Set to Soar"

.

StreetAuthority Catalyst Rating:
Business: Silver Mining
Enterprise Value:$4.8B
Operating Margin:42%
Proj. EPS Growth: +12%
Recent Price: $16.00
Buy Under: $20
Catalysts:

Spurred by inflation worries and increased industrial usage, silver demand is soaring (with silver prices following suit)

New purchasing deals will give this company millions of ounces of silver at a rock-bottom cost of only $4 an ounce -- about 75% cheaper than what everyone else pays for silver

This company's unique business model lets the firm reap all the benefits of appreciating silver but without the costs of digging and maintaining its own mines


You've probably heard a lot of talk about gold lately -- and for good reason. Gold is an indisputably reliable hedge against economic uncertainty. And given the unsteady dollar and ripe conditions for runaway inflation, it's no surprise that spot prices ascended about +34% in 2009 to hit record levels above $1,170 an ounce.

But you may be surprised to know that silver actually surged more than +60% -- climbing almost twice the rate of its yellow sibling. Yet, silver can still be had for just 1/60th the price of gold, a ratio well beyond historical norms.

My staff and I are confident that silver prices could easily rally another +50% from here. Aside from shielding investors from inflation, silver is also prized for its electrical and thermal conductivity and other unique properties. With commercial applications ranging from photography to medicine, industrial usage eats up approximately 60% of the world's supply each year.

Until recently, the industrial pool of demand has been playing tug-of-war with the inflation/dollar crowd. With economic growth back on track, these buyers will now work together to pull prices higher. Current estimates suggest there are only about 1 billion ounces above ground. Sovereign wealth funds from wealthy Gulf States like Dubai are buying up much of that.

None of this has gone unnoticed by retail investors. According to the U.S. Mint, the public scooped up 16.1 million American Eagle one-ounce silver coins in the first half of 2009 -- a sharp increase of +75% over the previous year. But you can do much better than bullion...

That's where Stock #4 comes in. As the world's largest silver streaming company, the firm buys future silver production from gold miners for relatively fixed prices, often below $4 an ounce. These deals are a win-win for both parties: The mine owners get upfront cash for what they consider to be a byproduct, while Stock #4 gets mounds of silver without having to shell out a penny for mine exploration or maintenance.

Management recently locked up an agreement that will hand over 25% of whatever silver is dug up from Goldcorp's Penasquito mine in Mexico. That deal alone is expected to yield 7.2 million ounces of silver annually for the next 22 years. The firm has 16 other agreements in place that will generate as much as 40 million ounces by 2013.

That increased production could send sales soaring +135% within the next four years without any increase in silver prices. Keep in mind, the company has minimal future capital expenditures, so any incremental sales growth will be converted into earnings.

In a recent quarter, sales of just 4.3 million ounces resulted in a record-shattering cash flow of $45 million, a +70% year-over-year increase. The combination of new deals and buoyant silver will send that total soaring over the next couple years.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


5. Stock #5 - This Stock Gained +151% Last Year and is Poised to Crush the S&P 500 Yet Again in 2010

.

StreetAuthority Catalyst Rating:
Business: Specialized semiconductors
Enterprise Value:$1.8B
Operating Margin:14%
Proj. EPS Growth: +20%
Recent Price: $12.26
Buy Under: $17
Catalysts:

The convergence of mobile devices and wireless broadband is fueling heavy demand for sophisticated handset chips. The sale of every iPhone represents cash in Stock #5's pocket.

The installation of over 150 million automated smart meters during the next five years will lead to $2 billion in annual chip sales that don't exist today. Stock #5 is an emerging leader in this nascent field.


Sometimes the best place for new money is a stock you already own. We remain highly bullish on the near and long-term growth prospects for Stock #5, one of the newest additions to our "Growth" Portfolio.

As a reminder to existing Market Advisor subscribers, this company benefits handsomely from the global migration to iPhones, Blackberries and other feature-rich smart phones. The firm's chips, which are used by all five of the major handset manufacturers to strengthen voice and data signals, have become nearly indispensable in today's 3G world.

With global Smartphone penetration forecast to triple to 60% from 20%, during the next five years orders will pile up even faster.

We just saw a sample of this last quarter. Third-quarter revenue climbed +19% from the prior period and came in several million dollars ahead of the upper end of internal targets. Meanwhile, operating income surged +50% to hit a new company record. Better still, order visibility is crystallizing and management has already upped its outlook for early 2010.

Diligent efforts to break into the wireless utility meter market are about to pay off in a big way now that the Obama administration just pledged $3.4 billion in grants to support smart grid development.

We think this company's CEO is being dead-level with shareholders when he says the firm is facing "powerful, multi-year growth waves" in mobile broadband and other areas. At just 12 times earnings, shares of this fast-growing company are trading at a sharp -40% discount to its +20%-plus projected growth rate.

That discrepancy won't last, and Stock #5 should ring up market-crushing gains in the next 12 months.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


6. Stock #6 - "Capitalize on Growth in China"

.

StreetAuthority Catalyst Rating:
Business: Metals/Minerals
Enterprise Value:$209B
Operating Margin:32%
Recent Price: $74.69
Buy Under: $84
Catalysts:

Stock #6 is a veritable commodities supermarket, with huge reserves of oil, coal, metals, diamonds and many other natural resources.

The firm has low production costs, a diversified revenue stream, and tight relationships with nearby Asian customers.


While the recession toppled nearly all of the world's major economies, it wasn't much more than a speed bump for China. After a brief pause, the Asian juggernaut is once again driving global growth.

As you might expect, this raw horsepower requires plenty of fuel. So in that sense, the simplest argument is to invest in whatever China needs.

Stock #6 stands ready to fill up the shopping cart. The Australian mining conglomerate is the world's leading supplier of metallurgical coking coal used in steel mills, as well as a top producer of thermal coal needed to fire power plants. But coal is just the beginning.

The company is most noted for its huge cache of iron ore, a critical raw material for steel production. It's also the world's third largest supplier of important base metals like nickel and copper, as well as a top aluminum producer -- handling over 1.3 million tons annually. Other products include lead, zinc, uranium and an array of ores and alloys.

If all that weren't enough, the firm also has oil & gas exploration activities from Algeria to the Gulf of Mexico. All of this is supported by a vertically-integrated network of rail lines, processing plants, ship-loaders and other assets. Every hour, the company can transfer 10,000 tons of ore onto giant vessels for transport to customers around the globe.

Stock #6 is swimming in natural resources -- and the world's hungriest consumer is right in its backyard. Last year China imported over 514 million tons of iron ore, a +37% increase over last year. Meanwhile, it has swallowed 2.6 million tons of refined copper, a surge of +165%.

Some of that stockpiling is speculative, but demand is clearly on the rise, thanks in part to China's massive $586 billion stimulus package.

Australia is arguably the strongest developed market in the world. The country added 40,000 new jobs last month, and it was the first G-20 state with the stability to raise interest rates. This flagship Australian powerhouse has rewarded investors with a gain of +145% during the past 12 months.

But as long as China and other trading partners need fuel to expand, there will be more where that came from.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


7. Stock #7 - "Monopoly Profits"

.

StreetAuthority Catalyst Rating:
Business: Advertising
Enterprise Value:$1.4B
Operating Margin:45%
Proj. EPS Growth: +27%
Recent Price: $14.81
Buy Under: $19
Catalysts:

After steep cutbacks to advertising budgets, companies of all shapes and sizes will soon spend heavily on marketing to attract new customers.

Because theatre advertising is far more effective than other mediums, Stock #7 commands premium rates and is attracting new clients.


Coping with the painful recession was tough. To compensate for the lack of cash coming in, virtually every company went into cost-cutting mode. Many suspended their dividends or delayed the purchase of new equipment -- anything to slash red ink from the books.

Unfortunately, the axe fell hard on advertising budgets. These deep cutbacks have helped many firms remain above water, but they are only a temporary solution.

We've reached a point where businesses in every industry will soon be forced to aggressively reach out to new customers, or risk falling behind the competition. The focus is already shifting in favor of sales growth -- and as they say, you have to spend money to make money.

After a year of backpedaling, we expect to see a sharp rebound in ad spending, be it print, billboard, online or any other medium. But advertisers will be smart and demand the most bang for the buck, which plays right into Stock #7's hands.

If you've been to the movies lately, chances are you were one of the 700,000 people to see the firm's exclusive "First Look" content while waiting for the show to start. Stock #7 dominates the cinema advertising market, having locked up 30-year agreements with leading exhibitors like Cinemark (NYSE: CNK) and Regal Entertainment (NYSE: RGC).

TV and magazine ads are little more than a distraction, but the theatre is a whole different ballgame. Moviegoers represent a captive audience that can't change the channel or block a pop-up ad. Studies have shown that 73% of theatre visitors can recall the commercials they saw, versus a mediocre television retention rate of 13%.

Not surprisingly, advertisers are willing to pay a premium to get their message out through this medium. Rates run 1.3 times those of primetime TV broadcasts.

In-theatre advertising is still in its infancy and only accounts for about $500 million in annual revenue -- a two-tenths of 1% drop in an overall $280 billion advertising bucket. But that is changing rapidly, and Stock #7 has been adding names like Lexus, Visa (NYSE: V), E*Trade (Nasdaq: ETFC) and Carnival Cruise Lines (NYSE: CCL) to its growing client roster.

Keep in mind, theatre partners pay for their own digital projection equipment, so ongoing expenditures are minimal and sales growth should scale nicely to the bottom line. We expect more companies than ever before to hand over a portion of their ad dollars to this high-impact channel in 2010 -- leading to a banner year for both Stock #7 and its shareholders.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


8. Stock #8 - "The Benefit Of Good Health"

.

StreetAuthority Catalyst Rating:
Business: Pharmaceutical Distribution
Enterprise Value:$16.2B
Proj. EPS Growth: +12%
Recent Price: $62.75
Buy Under: $71
Catalysts:

A massive influx of millions of new healthcare patients will stoke demand for flu shots, cholesterol drugs and thousands of other pharmaceutical products and medical supplies.

In an industry rife with inefficiencies, Stock #8's IT solutions will help eliminate duplicate tests and other common administrative snafus that waste as much as $900 million annually.


Big changes are on the horizon for the healthcare industry -- on that we can all agree. Unfortunately, nobody knows exactly what game-changing developments are in store. At this point, investors need a crystal ball to predict how Washington's inscrutable debate will play out.

But there are a few no-brainers that require no guesswork at all.

I honestly don't know the extent that sweeping regulatory overhauls will alter the playing field. But I can tell you one thing for sure: When you assimilate most of the nation's 47 million uninsured into the system, you get a much bigger system.

Millions of new patients (regardless of who's picking up the check) means a dramatically expanded marketplace for diagnostic tests, surgical procedures and, of course, prescription drugs. Stock #8 will be right in the middle of the action.

The company supplies more than 300,000 doctors' offices and hospitals with vaccines, medical supplies and surgical equipment. It's also the nation's leading drug wholesaler, distributing over $1 billion worth of medicine to pharmacies like Rite Aid (NYSE: RAD) and Wal-Mart (NYSE: WMT) each week. About one-third of North America's entire drug supply passes through the company's hands.

Stock #8 has also developed a wide range of software and products to support electronic health records and other digital initiatives -- one of the few reforms that both sides of the political aisle can agree on.

The firm's RelayHealth network is a connective portal that gives doctors, patients, pharmacies and insurance companies secure online access to shared patient information. Among many other uses, this next-generation product can facilitate e-prescriptions and support Internet-based physician consultations.

Only about 1-in-10 hospitals have entered the 21st century and upgraded to electronic record-keeping. President Obama's stimulus package included nearly $20 billion to speed up the transition. Thanks to incentive payments of up to $5 million for those that comply (and costly Medicare reimbursement penalties for those that don't), penetration rates for healthcare IT could soar to 55% for hospitals and 85% for doctors' offices within the next five years.

A "public option" might have insurers nervous, but it won't change things much for Stock #8.

The company already brings in over $100 billion in annual sales. Economies of scale have driven earnings up +65% over the past three years. Once the dust from the healthcare fray has settled, sales volume is headed nowhere but up -- and the stock will likely follow.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


9. Stock #9 - "Undervalued Gem"

.

StreetAuthority Catalyst Rating:
Business: Title Insurance
Enterprise Value:$3.5B
Proj. EPS Growth: +12%
Recent Price: $13.67
Buy Under: $17
Catalysts:

Record low mortgage rates, rising home values and an expansion of the homebuyer tax credit will all spur the housing market next year -- and every sale will involve title insurance.

After buying several title insurance groups from a bankrupt rival last year for just pennies on the dollar, Stock #9 now controls a commanding 50% share of the market.


As we pointed out earlier, companies around the globe are stepping up marketing efforts to push their products. Stock #9 probably won't be one of them; it has little need to advertise. After all, customers don't choose to buy the firm's title insurance -- they are obligated to.

If you've ever bought a home, then you probably understand the beauty behind Stock #9's business. Banks and other lenders won't hand out a dime without title insurance, which essentially guarantees that a property is unencumbered and the current owners have legal right to transfer the title to a buyer.

In most cases, there is nothing amiss, so the requirement is nothing more than a formality. That's why title insurance companies collect billions in premiums, pay out next to nothing in claims, and typically pocket about 95 cents from every dollar earned.

Of course, this is a transaction-based business. When the real estate market suffers, Stock #9 takes it on the chin. Fortunately, the firm didn't just weather last year's storm; it aggressively bought out a bankrupt rival for around $250 million. Management has already wrung out over a quarter-billion dollars in operational cost savings synergies from the merger.

Not only has the acquisition paid for itself, but it has given Stock #9 control of nearly 50% of the market. And with millions of residential and commercial properties changing hands each year, it's a big market.

The timing of this deal couldn't have been any better. Conditions have already begun to improve. At this point last year, the firm's title volume was running about 136,000 new orders per month. Now, that level is back up to 196,000 and rising.

The company had already generated $4.4 billion in sales through September 2009 -- more than it took in during all of 2008. More important, operating cash flow had totaled nearly $370 million, compared with a loss of $55 million at that point last year.

The future looks even brighter. Existing home sales surged +10.1% in October 2009 to their highest levels since February 2007. Median home values recently rose for the fifth straight month, which will help coax potential buyers off the fence and into realtors' offices.

Sub-5% mortgage rates and an expansion of the homebuyer's tax credit (which now includes a $6,500 incentive for current owners to upgrade) will also remain powerful catalysts.

The market isn't looking too far ahead at this point, and the shares are trading below book value -- meaning the firm's future profits can be had for free. In the meantime, one out of every two "sold" signs in the country means cash in Stock #9's pocket, enabling the firm to pay a generous 4.4% yield.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .


10. Stock #10 - The Agribusiness Sector Is Booming -- But Is Your Portfolio Going Along For The Ride?

.

StreetAuthority Catalyst Rating:
Category: Agriculture
Assets:$1.5B
Expense Ratio:0.59%
# of Holdings: 46
Recent Price: $42.56
Buy Under: $50
Catalysts:

We are on the threshold of a secular boom in agricultural commodities as demand swamps existing supplies, a fertile environment for companies in this sector.

Deep-pocketed G8 nations have pledged billions to help developing countries modernize agriculture techniques and optimize farmland.

Top Five Holdings: Potash (9.2%), Syngenta (8.0%), Mosaic (8.0%), Monsanto (7.4%), Wilmar (7.3%)


Last August, I told my Market Advisor readers a number of reasons why savvy investors see tremendous upside in agriculture stocks like Monsanto (NYSE: MON).

There are simple demographics: Rising global populations mean millions of new mouths to feed each year. At the same time, demand for biofuels is putting further strain on supplies -- ethanol production ate up more than one-fourth of the nation's corn harvest last year. Finally, rising incomes have led to a profound change in dietary habits from starch to protein.

China's annual per-capita meat annual consumption has nearly tripled to 110 pounds, from 40 pounds in 1980. Of course, chickens and cows must also be fed. In fact, it takes seven pounds of grain to produce one pound of meat. Increased meat consumption has whetted the hearty global appetite for livestock feed, too.

Food, fuel and feed -- three different groups all hungry for the same crops.

Unfortunately, the amount of arable land is shrinking. According to my colleague Amy Calistri, the amount of farmland per person has been cut in half, dropping from 1.1 acres in 1960 to 0.6 acres today.

That means farmers around the world will be challenged to grow more from each acre of soil, and they will need the help of companies like Monsanto to do so.

But the genetically-enhanced seed maker will have plenty of company. To enhance crop yields, farmers will need to spend heavily on fertilizer, tractors, irrigation equipment and other specialized products. You'll find nearly all of the industry's biggest players in Stock #10's holdings.

The portfolio includes well-known names like Potash Corp. of Saskatchewan (NYSE: POT), whose crop nutrients are becoming vital to India and China. One-third of the world's population lives there, but each acre of farmland spits out less than half that in the United States.

Shareholders will also have a stake in food producers like Tyson, heavy equipment manufacturers such as Japan's Kubota (NYSE: KUB), and processing specialists like China Agri-Industries. Overall, the fund tracks the performance of nearly 50 companies representing over a dozen countries.

With impressive annualized gains of +27%, the agriculture group has been one of the market's top three sectors during the past five years. These stocks were hit hard by the recent downturn and haven't yet gotten back on their feet -- Monsanto, for example, is trading at less than half its former peak near $150 a share.

That has opened up a golden window of opportunity. A rebounding global economy and looser credit will help unlock pent-up demand for fertilizer, seeds and equipment. And a tumbling dollar should only sweeten profits for domestic companies operating in foreign markets.

Let's not forget, the G-8 nations have also pledged up to $20 billion in aid to help struggling emerging markets expand their agricultural output to put more food on the table. And there are several other wild cards that could generate enthusiasm from the investment community -- like a dry monsoon season in India and other supply disruptions.

In any case, demand for food is unwavering, so cash will continue sprouting in the agriculture sector in 2010 -- and we think Stock #10 is the best way to profit.

You'll find complete details on this company -- including its name and ticker symbol -- in our newest in-depth research report, Market Advisor's Top Ten Stocks for 2010 . . .

Subscribe to our Market Advisor newsletter today and you'll receive this full report -- Market Advisor's Top Ten Stocks for 2010 -- instantly. Along with your subscription, you'll get the names and ticker symbols of all of the companies we've mentioned in today's sneak preview, plus dozens of additional stocks to bank on in 2010!

Market Advisor
only from . . .

StreetAuthority.com is a research-intensive financial publishing firm that aims to level the playing field for small investors by giving them access to the ideas and insights of some of the country's top independent investment analysts.

In times of economic, political and market uncertainty like we face today, individual investors need professional guidance more than ever. More importantly, they need advice from a reputable information source that they can trust. StreetAuthority is exactly that kind of company for so many reasons. Here are just a few of the things that separate us from the competition . . .

Experience -- Our team of researchers, editors and journalists has well over 100 years of combined experience in the equity and bond markets.

Unique Investing Methodology -- Our writers and researchers specialize in uncovering investment ideas and opportunities that are often overlooked by more conventional Wall Street sources. When you subscribe to the Market Advisor, you'll immediately notice a major difference between our content and that which you might find elsewhere.

Proven Track Record -- When we say profitable, we mean it. We go out of our way to hire only the most qualified investment personalities on and off of Wall Street. What we're left with is an experienced team of researchers with a documented track record of tremendous success.

Unbiased Research -- We pride ourselves on the quality and independence of our equity research, and we'd like to assure you that we are a 100% unbiased source of investing information. We will never accept any compensation of any kind from the companies that we cover in our newsletters or on our web site.

Reasonable Prices -- Other financial research groups sell similar investment services and products for thousands of dollars a year. However, you can subscribe to our Market Advisor service for just $39.50 for three months. That's less than $40 for information that could help you generate thousands of dollars in annual profits!

Focus on YOU -- Our company policies prohibit our writers from buying/selling any of the stocks we cover at least seven days before or after we add/remove them from our model portfolios. By incorporating these and other similar policies into our way of doing business, we ensure that our subscribers' interests come first.


Receive a Full Year of our Market Advisor Newsletter -- Plus Much, Much More . . .


We think it's important to stress just how much content and value is included with a subscription to our Market Advisor newsletter. It's more than just a newsletter -- it's a comprehensive investing service designed to help you make the most informed decisions for your portfolio.

It's also a highly diversified service -- the Market Advisor covers income investments, undervalued stocks, aggressive growth plays, international investments, exchange-traded funds, and just about everything else in between. As a result, you're certain to find a variety of investing ideas that are well suited for your portfolio. And because we also include top-notch educational content in our newsletters, you're also likely to learn something new and valuable in each and every issue.

Here's everything you'll get for the low price of just $39.50:


Market Advisor's Top Ten Stocks for 2010

This in-depth research report brings you a closer look at our top investing ideas for the coming year.

A Full Year of our Market Advisor Newsletter
Published monthly, each issue of the Market Advisor is loaded with dozens of new investing ideas, educational articles, and in-depth industry analysis.

Access to Four Model Portfolios
You'll gain immediate access to four model portfolios arranged into such categories as Aggressive Growth, Yield-Maximizer and Undervalued Gems. You will also gain access to our "Beat the S&P" Portfolio, which has outperformed the S&P by a 2-to-1 margin since its inception back in 2003. No matter what your investing style, you're certain to find plenty of profitable ideas here.

Subscribers-Only Web Site Content
Your subscription comes with complete access to all of our premium Market Advisor web site content, including access to our issue archives, news flashes, and a host of valuable educational materials.

Additional In-Depth Research Reports
Subscribe today and you'll also receive up to THREE additional research reports at no extra charge . . .


Our Unconditional 90-Day Guarantee
You can cancel your subscription at any time by clicking on the easy unsubscribe link we provide at the bottom of every single newsletter we send you. Take 90 days of your initial term to test our Market Advisor newsletter out. If you decide to cancel any time within those first 90 days of your initial term, then we'll return your entire subscription fee -- every single cent. You'll also get to keep all of our in-depth research reports -- including Market Advisor's Top Ten Stocks for 2010 -- as a special thank-you gift just for trying out the newsletter. You truly have nothing to lose.



You don't have to take our word for it!


Here's what some of our more than 400,000 loyal subscribers have had to say about our service . . .

"Thank you for your Market Advisor newsletter. I have been using your newsletter for three months and I am ahead over $30,000 on the stocks you have profiled. I could not even come close to doing this if I were investing alone."
-- R. Wilson (Jacksonville, FL)

"I am a subscriber of your Market Advisor investment newsletter, and I am very impressed by the success of your stock recommendations over the past year. I have followed some of your recommendations and made a healthy profit from several of your ideas. I congratulate you again for the excellent services that you provide to your subscribers. Keep up the good work."
-- Alexandros Politis-Kalenteris (Athens, Greece)

"I have found your Market Advisor newsletters and updates to be better than any others. I should also mention that I have reviewed well over 40 newsletters during the past year. What I liked about StreetAuthority is the investment diversification you cover in the web site and newsletter. Keep up the good work. I have been referring you to friends and family."
-- S. D'Urso (St. Petersburg, FL)

"I'm just writing to let you know how much I have been enjoying the Market Advisor. In addition to your market summaries, I really like the steady stream of new investing ideas you give us."
-- R. Brenner (San Antonio, TX)

"Having read hundreds of financial newsletters on an ongoing basis for over 23 years, I can tell you that StreetAuthority's services are among the very best in the business. I am continually amazed at the broad range of in-depth and consistently excellent research that you offer to your readers. Keep up the good work!"
-- Steven Halpern (Editor, World Money Show)


Examine the StreetAuthority Market Advisor at Our
Lowest Rate Ever . . . and with ZERO Risk


Because we're so sure that once you examine just one issue of the Market Advisor you'll become a subscriber for the long haul, we invite you to try this newsletter for only $39.50 for a one-year subscription. That's less than $40 for information that could help you generate tens of thousands of dollars in annual profits!

And remember -- our subscription comes with absolutely zero risk. Cancel any time within the first 90 days and we'll return your entire subscription fee -- every single cent. You'll also get to keep our in-depth research report -- Market Advisor's Top Ten Stocks for 2010 -- as a special thank-you gift just for trying out the newsletter.

In addition, even if you decide to keep your subscription beyond those first 90 days, then we'll still eliminate your risk. Cancel any time after 90 days and we'll provide you with a pro-rated refund for the entire unused portion of your subscription. It's as easy as that.

Best of all, you can now subscribe to our Market Advisor newsletter, which includes Market Advisor's Top Ten Stocks for 2010 -- at the lowest price we've ever offered: just $39.50 for a three month subscription. No need to wait for a better price. This is the absolute best deal we will EVER offer -- guaranteed.

So, register now to receive the information you need to take your portfolio to the next level. Follow the link below to gain immediate access to our newest research report -- Market Advisor's Top Ten Stocks for 2010, plus a full year of our Market Advisor newsletter, plus access to our members-only web site content, plus several other in-depth research reports.

We want you to feel 100% comfortable with our analysis and our Market Advisor newsletter, otherwise we don't want your money. You'll either come away satisfied, or you won't pay us a single cent. That's our promise to you.

But remember -- you only have a few days left to lock in this special discount AND receive our in-depth research report -- Market Advisor's Top Ten Stocks for 2010 -- at no additional charge! Don't delay, visit the link above to take advantage of this offer today.


On behalf of our entire staff here at StreetAuthority.com, I'd like to thank you for taking the time to read today's introductory analysis of our Top Ten Stocks for 2010. Whether you choose to receive the full report and to give our Market Advisor newsletter a try or not, I sincerely hope you've benefited from today's analysis.

We look forward to helping you make 2010 your most profitable investing year ever!

Sincerely,


Lou Betancourt
Publisher
StreetAuthority.com
http://web.StreetAuthority.com

StreetAuthority LLC
P.O. Box 83217
Gaithersburg MD 20883-3217
USA

P.S. -- This special offer could expire for good in just a few short days. Act now to reserve three months of the Market Advisor for just $39.50 and to receive immediate access to our newest in-depth research report -- Market Advisor's Top Ten Stocks for 2010. You'll also receive instant access to premium web site content, four model portfolios, and up to THREE additional research reports. Don't delay, subscribe today and start receiving the information you need to take your portfolio to the next level!